{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:26:39Z","timestamp":1786994799388,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"am","delay-in-days":291,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG034570"],"award-info":[{"award-number":["AG034570"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG062542"],"award-info":[{"award-number":["AG062542"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.neurobiolaging.2022.03.005","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T19:11:24Z","timestamp":1647285084000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Rates of \u03b2-amyloid deposition indicate widespread simultaneous accumulation throughout the brain"],"prefix":"10.1016","volume":"115","author":[{"given":"Molly R.","family":"LaPoint","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0209-3127","authenticated-orcid":false,"given":"Suzanne L.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Landau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2036-3496","authenticated-orcid":false,"given":"Theresa M.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4458-113X","authenticated-orcid":false,"given":"William J.","family":"Jagust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.49132","article-title":"Cortical tau deposition follows patterns of entorhinal functional connectivity in aging","volume":"8","author":"Adams","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0002","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2967\/jnumed.116.175273","article-title":"Reference tissue-based kinetic evaluation of 18F-AV-1451 for tau imaging","volume":"58","author":"Baker","year":"2017","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0003","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.dib.2017.10.024","article-title":"Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data","volume":"15","author":"Baker","year":"2017","journal-title":"Data Br"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0004","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1007\/s00259-017-3666-8","article-title":"Reference region selection and the association between the rate of amyloid accumulation over time and the baseline amyloid burden","volume":"44","author":"Blautzik","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0006","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neurobiolaging.2020.06.001","article-title":"Impact of APOE-\u03b54 carriage on the onset and rates of neocortical A\u03b2-amyloid deposition","volume":"95","author":"Burnham","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0007","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ana.24711","article-title":"In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum","volume":"80","author":"Cho","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0008","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/nn.3806","article-title":"Neural compensation in older people with brain amyloid-\u03b2 deposition","volume":"17","author":"Elman","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0009","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s11065-014-9263-8","article-title":"Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan","volume":"24","author":"Fouquet","year":"2014","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-14159-1","article-title":"Functional brain architecture is associated with the rate of tau accumulation in Alzheimer's disease","volume":"11","author":"Franzmeier","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0011","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1212\/WNL.0000000000004643","article-title":"In vivo staging of regional amyloid deposition","volume":"89","author":"Grothe","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0012","first-page":"2755","article-title":"Molecular properties underlying regional vulnerability to Alzheimer's disease pathology","volume":"141","author":"Grothe","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0013","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2967\/jnumed.116.176115","article-title":"Predicting regional pattern of longitudinal \u03b2-amyloid accumulation by baseline PET","volume":"58","author":"Guo","year":"2017","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0014","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.jalz.2018.05.013","article-title":"Rate of \u03b2-amyloid accumulation varies with baseline amyloid burden: Implications for anti-amyloid drug trials","volume":"14","author":"Guo","year":"2018","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nm.4443","article-title":"Amyloid-\u03b2 plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation","volume":"24","author":"He","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/braincomms\/fcaa007","article-title":"Neuroanatomical spread of amyloid \u03b2 and tau in Alzheimer's disease: implications for primary prevention","volume":"2","author":"Insel","year":"2020","journal-title":"Brain Commun"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0017","first-page":"535","article-title":"NIA-AA research framework: toward a biological definition of alzheimer's disease. Alzheimer's dement","volume":"14","author":"Jack","year":"2018","journal-title":"Silverberg, N.,"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0018","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/awm336","article-title":"11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment","volume":"131","author":"Jack","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0019","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0b013e3182840bbe","article-title":"Brain \u03b2-amyloid load approaches a plateau","volume":"80","author":"Jack","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0020","doi-asserted-by":"crossref","unstructured":"Jagust, W.J., Landau, S.M., 2021. Temporal dynamics of beta-amyloid accumulation in aging and Alzheimer's disease. Neurology doi:10.1212\/WNL.0000000000011524","DOI":"10.1212\/WNL.0000000000011524"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0021","first-page":"1","article-title":"Longitudinal validity of PET-based staging of regional amyloid deposition","author":"Jelistratova","year":"2020","journal-title":"Hum. Brain Mapp"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0022","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.24546","article-title":"Tau positron emission tomographic imaging in aging and early Alzheimer disease","volume":"79","author":"Johnson","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0023","doi-asserted-by":"crossref","unstructured":"Klunk, W.E., Koeppe, R.A., Price, J.C., Benzinger, T.L., Devous, M.D., Jagust, W.J., Johnson, K.A., Mathis, C.A., Minhas, D., Pontecorvo, M.J., Rowe, C.C., Skovronsky, D.M., Mintun, M.A., 2015. The centiloid project: standardizing quantitative amyloid plaque estimation by PET. Alzheimer's dement. 11, 1-15.e4. doi:10.1016\/j.jalz.2014.07.003","DOI":"10.1016\/j.jalz.2014.07.003"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0024","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1523\/JNEUROSCI.0485-18.2018","article-title":"Subthreshold amyloid predicts tau deposition in aging","volume":"38","author":"Leal","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0025","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1212\/WNL.0000000000004336","article-title":"APOE genotype and early \u03b2-amyloid accumulation in older adults without dementia","volume":"89","author":"Lim","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0026","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuroimage.2017.02.051","article-title":"Amyloid and tau PET demonstrate region-specific associations in normal older people","volume":"150","author":"Lockhart","year":"2017","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0027","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00004647-199609000-00008","article-title":"Distribution volume ratios without blood sampling from graphical analysis of PET data","volume":"16","author":"Logan","year":"1996","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0028","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neurobiolaging.2020.05.012","article-title":"Influence of apolipoprotein-E genotype on brain amyloid load and longitudinal trajectories","volume":"94","author":"Lopresti","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0029","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1021\/jm030026b","article-title":"Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents","volume":"46","author":"Mathis","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0030","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jamaneurol.2019.2214","article-title":"Staging \u03b2 -amyloid pathology with amyloid positron emission tomography","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0031","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/brain\/awy103","article-title":"Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE \u03f54 genotype","volume":"141","author":"Mishra","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0032","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/brain\/awn320","article-title":"Episodic memory loss is related to hippocampal-mediated \u03b2-amyloid deposition in elderly subjects","volume":"132","author":"Mormino","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0033","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1093\/cercor\/bhr025","article-title":"Relationships between beta-amyloid and functional connectivity in different components of the default mode network in aging","volume":"21","author":"Mormino","year":"2011","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0034","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/brain\/aww108","article-title":"Dynamic relationships between age, amyloid-\u03b2 deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease","volume":"139","author":"Oh","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01150-x","article-title":"Earliest accumulation of \u03b2-amyloid occurs within the default-mode network and concurrently affects brain connectivity","volume":"8","author":"Palmqvist","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0036","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jalz.2016.11.005","article-title":"Synergistic interaction between amyloid and tau predicts the progression to dementia","volume":"13","author":"Pascoal","year":"2017","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0037","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/sj.jcbfm.9600146","article-title":"Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh compound-B","volume":"25","author":"Price","year":"2005","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0038","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.neurobiolaging.2015.04.001","article-title":"Changes in A\u03b2 biomarkers and associations with APOE genotype in 2 longitudinal cohorts","volume":"36","author":"Resnick","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0039","first-page":"904","article-title":"Correction for partial volume effects in PET\u00a0: principle and validation . J correction for partial volume effects in PET\u00a0: principle and validation","volume":"39","author":"Rousset","year":"1998","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0040","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/j.1742-4658.2010.07568.x","article-title":"Amyloid oligomers: formation and toxicity of A\u03b2 oligomers","volume":"277","author":"Sakono","year":"2010","journal-title":"FEBS J"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-019-0466-3","article-title":"Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: The INSIGHT-preAD study","volume":"11","author":"Sakr","year":"2019","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0042","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejmech.2016.02.065","article-title":"Structure of amyloid oligomers and their mechanisms of toxicities: targeting amyloid oligomers using novel therapeutic approaches","volume":"114","author":"Salahuddin","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0043","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","article-title":"PET imaging of tau deposition in the aging human brain","volume":"89","author":"Sch\u00f6ll","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0044","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease\u00a0: recommendations from the national institute on aging-Alzheimer \u2019 s association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0045","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neurobiolaging.2020.03.011","article-title":"In vivo staging of regional amyloid deposition predicts functional conversion in the preclinical and prodromal phases of Alzheimer's disease","volume":"93","author":"Teipel","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0046","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0047","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/brain\/awx046","article-title":"Association between tau deposition and antecedent amyloid-\u03b2 accumulation rates in normal and early symptomatic individuals","volume":"140","author":"Tosun","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0048","first-page":"21","article-title":"Tau-PET uptake\u00a0: Regional variation in average SUVR and impact of amyloid deposition","volume":"6","author":"Vemuri","year":"2017","journal-title":"Alzheimer's Dement. Diagnosis, Assess. Dis. Monit."},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0049","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0050","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/brain\/awv112","article-title":"Existing Pittsburgh compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation","volume":"138","author":"Villeneuve","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0051","doi-asserted-by":"crossref","first-page":"17763","DOI":"10.1073\/pnas.1010461107","article-title":"Spatial correlation between brain aerobic glycolysis and amyloid-\u03b2 (A\u03b2) deposition","volume":"107","author":"Vlassenko","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0052","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/s41467-020-15701-2","article-title":"Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease","volume":"11","author":"Vogel","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0053","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2967\/jnumed.117.194720","article-title":"Spatiotemporal distribution of B-Amyloid in Alzheimer disease is the result of heterogeneous regional carrying capacities","volume":"59","author":"Whittington","year":"2018","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2022.03.005_bib0054","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1016\/j.neurobiolaging.2013.05.030","article-title":"Memory decline shows stronger associations with estimated spatial patterns of amyloid deposition progression than total amyloid burden","volume":"34","author":"Yotter","year":"2013","journal-title":"Neurobiol. Aging"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458022000471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458022000471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:41:24Z","timestamp":1759318884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458022000471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":54,"alternative-id":["S0197458022000471"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.03.005","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rates of \u03b2-amyloid deposition indicate widespread simultaneous accumulation throughout the brain","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}